Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Operating Cash Flow per Share : $-0.03 (TTM As of Apr. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Operating Cash Flow per Share?

Advanced Proteome Therapeutics's operating cash flow per share for the three months ended in Apr. 2023 was $-0.02. Advanced Proteome Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Apr. 2023 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Advanced Proteome Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

APTCF's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Advanced Proteome Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Advanced Proteome Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Operating Cash Flow per Share Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.08

-0.04

-0.02

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-	-0.02

Competitive Comparison of Advanced Proteome Therapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Proteome Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Price-to-Operating-Cash-Flow falls into.

Advanced Proteome Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Advanced Proteome Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Jul. 2022 is calculated as

Operating Cash Flow per Share (A: Jul. 2022 )	=	Cash Flow from Operations (A: Jul. 2022 )	/	Shares Outstanding (Diluted Average) (A: Jul. 2022 )
	=	-0.694	/	39.088
	=	-0.02

Advanced Proteome Therapeutics's Operating Cash Flow per Share for the quarter that ended in Jul. 2022 is calculated as

Operating Cash Flow per Share (Q: Apr. 2023 )	=	Cash Flow from Operations (Q: Apr. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Apr. 2023 )
	=	-0.712	/	40.711
	=	-0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

Advanced Proteome Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

0E81:Germany APC.H:Canada

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018